Advances in Affective Disorders

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: closed (20 March 2024) | Viewed by 908

Special Issue Editors


E-Mail
Guest Editor
“Nuestra Señora del Pilar” Psychosocial Rehabilitation Center, C/ Duquesa de Villahermosa, 66, 50009 Zaragoza, Spain
Interests: psychiatry; affective disorders; mood disorders

E-Mail
Guest Editor
Department of Microbiology, Pediatrics, Radiology, and Public Health, University of Zaragoza, C/Domingo Miral s/n, 50009 Zaragoza, Spain
Interests: epidemiology; biostatistics; aging; mental health; dementia; anxiety; depression
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Affective disorders continue to be a significant area of investigation, as researchers strive to deepen our understanding of the complex interplay between biological, psychological, and social factors that contribute to these conditions. Current research has witnessed remarkable progress across various domains. Advances in neuroimaging techniques have shed light on the underlying neural circuitry and molecular mechanisms, paving the way for more targeted interventions.

In the realm of treatment, a multidisciplinary approach has gained momentum, emphasizing the importance of collaborative care. Novel therapeutic modalities in the field of psychotherapy, mindfulness-based interventions, and psychopharmacological advancements have shown promise in enhancing symptom management and improving overall well-being. We welcome a diverse range of topics, including novel diagnostic approaches and assessment tools, the exploration of treatment interventions, including pharmacological and non-pharmacological approaches, genetic and neurobiological advancements, comorbidity and its implications for clinical management, and translational and clinical research. 

Our journal serves as a platform for you to share and disseminate your valuable contributions and shape the future of affective disorders research. I strongly encourage you to submit your original research or review papers to our journal and be a part of our vibrant scientific community. Together, let us expand our knowledge, challenge prevailing paradigms, and make a lasting impact on the lives of affected individuals.

Dr. Juan Bueno-Notivol
Dr. Javier Santabárbara
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • affective disorders
  • mood disorders
  • treatment interventions
  • psychosocial factors
  • diagnosis
  • aetiology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 242 KiB  
Article
The Role of Metacognition in the Prediction of Depressive and Anxiety Symptoms in Chronically Ill Patients
by Agata Kołodziejczyk, Julia Krawczyk, Elżbieta Tkaczyszyn-Mika, Julia Gniewczyńska, Michał Ziarko, Dorota Zozulińska-Ziółkiewicz and Tomasz Pawłowski
J. Clin. Med. 2024, 13(5), 1306; https://doi.org/10.3390/jcm13051306 - 25 Feb 2024
Viewed by 686
Abstract
Introduction: Cancer, diabetes, and heart diseases are frequent causes of depression and anxiety. The study explored the metacognitive beliefs manifested by chronically ill patients and the presence of depressive or anxiety symptoms and the predictive role of metacognition in both. Methods: A total [...] Read more.
Introduction: Cancer, diabetes, and heart diseases are frequent causes of depression and anxiety. The study explored the metacognitive beliefs manifested by chronically ill patients and the presence of depressive or anxiety symptoms and the predictive role of metacognition in both. Methods: A total of 254 chronically ill patients participated in the study. The Metacognitive Questionnaire was used to measure the patients’ metacognitive beliefs, whereas the Hospital Anxiety and Depression Scale was applied to evaluate their psychopathological symptoms. A correlation analysis was performed to explore the relationships between metacognition and psychopathological symptoms. Regression analyses were conducted to examine the predictive role of metacognition in anxiety and depression. Results: The Negative Beliefs about Uncontrollability and Danger scale correlated with both anxiety and depression scales, and the Cognitive Confidence scale correlated with the depression scale. Linear regression analyses indicated that metacognitive beliefs were responsible for 32.2% of the variance of anxiety symptoms among all the chronically ill. Metacognitive beliefs accounted for 48.8% of the variance in anxiety symptoms and 36.6% in depressive symptoms among diabetes patients. Conclusions: There are specific correlations between psychopathological symptoms and metacognition among chronically ill patients. Metacognitions have a moderate role in developing and sustaining anxiety and depressive symptoms. Full article
(This article belongs to the Special Issue Advances in Affective Disorders)
Back to TopTop